HPCM
REGN icon

Hunter Perkins Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Hunter Perkins Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46M Sell
10,356
-631
-6% -$430K 1.45% 19
2026
Q1 		$8.49M Buy
10,987
+100
+0.9% +$76.6K 1.99% 13
2025
Q4 		$8.4M Sell
10,887
-729
-6% -$495K 1.94% 13
2025
Q3 		$6.53M Buy
11,616
+3,143
+37% +$1.78M 1.45% 23
2025
Q2 		$4.45M Sell
8,473
-9
-0.1% -$5.02K 1.05% 31
2025
Q1 		$5.38M Buy
+8,482
New +$5.83M 1.25% 26

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Hunter Perkins Capital Management's REGN Position: Q2 2026 in Review

Hunter Perkins Capital Management reduced its Regeneron Pharmaceuticals (REGN) stake by 5.7% in Q2 2026, selling an estimated $430K and leaving 10,356 shares worth $6.46M. The position accounts for 1.45% of the portfolio, ranked #19.

Hunter Perkins Capital Management first reported a position in REGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.49M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Hunter Perkins Capital Management held 10,356 shares of Regeneron Pharmaceuticals worth $6.46M as of Q2 2026.
  • Hunter Perkins Capital Management sold 631 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $430K.
  • Regeneron Pharmaceuticals made up 1.45% of Hunter Perkins Capital Management's portfolio in Q2 2026, its #19 holding.
  • Hunter Perkins Capital Management first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Hunter Perkins Capital Management's Regeneron Pharmaceuticals position peaked at $8.49M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Hunter Perkins Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.